HK95697A - 5-HT1-like receptor agonist for rectal administration - Google Patents

5-HT1-like receptor agonist for rectal administration Download PDF

Info

Publication number
HK95697A
HK95697A HK95697A HK95697A HK95697A HK 95697 A HK95697 A HK 95697A HK 95697 A HK95697 A HK 95697A HK 95697 A HK95697 A HK 95697A HK 95697 A HK95697 A HK 95697A
Authority
HK
Hong Kong
Prior art keywords
pct
receptor agonist
rectal administration
sec
date
Prior art date
Application number
HK95697A
Other languages
English (en)
Inventor
Merlet Nadine
Richard Isabelle
Thielemans Isabelle
Original Assignee
Laboratoire Glaxo Wellcome
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Glaxo Wellcome filed Critical Laboratoire Glaxo Wellcome
Publication of HK95697A publication Critical patent/HK95697A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
HK95697A 1992-05-07 1997-06-26 5-HT1-like receptor agonist for rectal administration HK95697A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929209882A GB9209882D0 (en) 1992-05-07 1992-05-07 Compositions

Publications (1)

Publication Number Publication Date
HK95697A true HK95697A (en) 1997-08-08

Family

ID=10715158

Family Applications (1)

Application Number Title Priority Date Filing Date
HK95697A HK95697A (en) 1992-05-07 1997-06-26 5-HT1-like receptor agonist for rectal administration

Country Status (33)

Country Link
US (1) US5705506A (enExample)
EP (1) EP0639072B1 (enExample)
JP (1) JPH07506570A (enExample)
KR (1) KR100253111B1 (enExample)
AT (1) ATE163850T1 (enExample)
AU (1) AU670083B2 (enExample)
BE (1) BE1007024A5 (enExample)
BG (1) BG62120B1 (enExample)
BR (1) BR1100108A (enExample)
CA (1) CA2135179C (enExample)
CH (1) CH685920A5 (enExample)
CY (1) CY2039B1 (enExample)
CZ (1) CZ283512B6 (enExample)
DE (1) DE69317418T2 (enExample)
ES (1) ES2113533T3 (enExample)
FR (1) FR2690847B1 (enExample)
GB (2) GB9209882D0 (enExample)
GR (1) GR3026584T3 (enExample)
HK (1) HK95697A (enExample)
HU (2) HU227338B1 (enExample)
IE (1) IE75203B1 (enExample)
IL (1) IL105468A (enExample)
IT (1) IT1261471B (enExample)
NO (1) NO306700B1 (enExample)
NZ (1) NZ252132A (enExample)
OA (1) OA10109A (enExample)
RO (1) RO112993B1 (enExample)
RU (1) RU2118527C1 (enExample)
SG (1) SG46649A1 (enExample)
TW (1) TW231970B (enExample)
UA (1) UA37206C2 (enExample)
WO (1) WO1993021916A1 (enExample)
ZA (1) ZA933178B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2434297A (en) * 1996-05-23 1997-12-09 Alcon Laboratories, Inc. The use of 5-ht1b/1d agonists to treat ocular pain
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
PT1421939E (pt) * 1998-03-26 2010-07-12 Astellas Pharma Inc Preparaã†o da libertaã†o sustentada de um composto de macrëlido como tracolimus
WO2000051624A2 (en) * 1999-03-05 2000-09-08 The Trustees Of University Technology Corporation Methods and compositions useful in inhibiting apoptosis
AR056690A1 (es) * 2005-10-14 2007-10-17 Athersys Inc Derivados de indol como inhibidores de indol como inhibidores del receptor 3 de histamina para el tartamiento de trastornos del sueno y cognitivos obesidad y otros trastornos de snc
SI2124556T1 (sl) 2006-10-09 2015-01-30 Charleston Laboratories, Inc. Farmacevtske sestave
CA2905541C (en) 2008-01-09 2020-02-11 Charleston Laboratories, Inc. Pharmaceutical compositions comprising an antiemetic and an opioid analgesic
EP3311667A1 (en) 2009-07-08 2018-04-25 Charleston Laboratories, Inc. Pharmaceutical compositions
AU2011316225B2 (en) 2010-10-15 2016-05-19 Contera Pharma Aps Combinations of serotonin receptor agonists for treatment of movement disorders
BR112014025907B1 (pt) 2012-04-18 2023-02-14 Contera Pharma Aps Formulação farmacêutica disponível para administração por via oral adequada para manejo aprimorado de transtornos do movimento
CA3055170A1 (en) 2016-03-04 2017-09-08 Charleston Laboratories, Inc. Pharmaceutical compositions
AU2017297718B2 (en) 2016-07-11 2023-06-08 Contera Pharma A/S Pulsatile drug delivery system for treating morning akinesia

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW19381A1 (en) * 1980-08-12 1983-03-09 Glaxo Group Ltd Heterocyclic compounds
FR2488606A1 (fr) * 1980-08-12 1982-02-19 Glaxo Group Ltd Derives indoliques, leur preparation et leurs applications en tant que medicaments
GB2082175B (en) * 1980-08-12 1984-05-02 Glaxo Group Ltd Heterocyclic compounds
GR79215B (enExample) * 1982-06-07 1984-10-22 Glaxo Group Ltd
HU196752B (en) * 1983-12-06 1989-01-30 Glaxo Group Ltd Process for production of medical compositions containing indole-derivatives and these compounds
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
DE3542698A1 (de) * 1984-12-04 1986-06-05 Glaxo Group Ltd., London Indolderivate, verfahren zu ihrer herstellung und sie enthaltende, pharmazeutische zubereitungen
GB8431426D0 (en) * 1984-12-13 1985-01-23 Glaxo Group Ltd Chemical compounds
EP0225726B1 (en) * 1985-11-08 1991-04-17 Glaxo Group Limited Indole derivatives
IL87437A0 (en) * 1987-08-13 1989-01-31 Glaxo Group Ltd Indole derivatives,their preparation and pharmaceutical compositions containing them
PT97888B (pt) * 1990-06-07 1998-12-31 Zeneca Ltd Processo para a preparacao de compostos heterociclicos derivados de indol e de composicoes farmaceuticas que os contem

Also Published As

Publication number Publication date
IL105468A0 (en) 1993-08-18
GB9309209D0 (en) 1993-06-16
SG46649A1 (en) 1998-02-20
IT1261471B (it) 1996-05-23
CZ272394A3 (en) 1995-10-18
CA2135179C (en) 2000-12-05
RU2118527C1 (ru) 1998-09-10
HU211638A9 (en) 1995-12-28
DE69317418D1 (de) 1998-04-16
ITRM930286A1 (it) 1994-11-06
CY2039B1 (en) 1998-04-30
GB2266665A (en) 1993-11-10
ATE163850T1 (de) 1998-03-15
ITRM930286A0 (it) 1993-05-06
CA2135179A1 (en) 1993-11-11
FR2690847A1 (fr) 1993-11-12
JPH07506570A (ja) 1995-07-20
NO306700B1 (no) 1999-12-13
UA37206C2 (uk) 2001-05-15
HUT71418A (en) 1995-11-28
NZ252132A (en) 1996-09-25
ES2113533T3 (es) 1998-05-01
HU227338B1 (en) 2011-04-28
RO112993B1 (ro) 1998-03-30
IL105468A (en) 1998-09-24
CH685920A5 (fr) 1995-11-15
NO944214D0 (no) 1994-11-04
BR1100108A (pt) 1999-12-07
KR100253111B1 (en) 2000-07-01
GB2266665B (en) 1996-05-22
NO944214L (no) 1994-11-07
TW231970B (enExample) 1994-10-11
EP0639072A1 (en) 1995-02-22
IE930339A1 (en) 1993-11-17
AU4064093A (en) 1993-11-29
CZ283512B6 (cs) 1998-04-15
DE69317418T2 (de) 1998-07-30
GB9209882D0 (en) 1992-06-24
EP0639072B1 (en) 1998-03-11
IE75203B1 (en) 1997-08-27
OA10109A (en) 1996-12-18
BE1007024A5 (fr) 1995-02-21
WO1993021916A1 (en) 1993-11-11
BG99167A (bg) 1995-06-30
FR2690847B1 (fr) 1995-06-09
AU670083B2 (en) 1996-07-04
GR3026584T3 (en) 1998-07-31
US5705506A (en) 1998-01-06
ZA933178B (en) 1994-01-10
BG62120B1 (bg) 1999-03-31

Similar Documents

Publication Publication Date Title
WO2003037271A3 (en) Compounds, pharmaceutical compositions and methods of use therefor
IL127244A (en) Substituted amines, methods of their preparation and pharmaceutical compositions containing them
CA2366268A1 (en) Pharmaceutical compositions for cns and other disorders
ES2160949T3 (es) Derivados de fenilen-sulfonamida sustituidos en meta.
EP0903349A3 (en) CCR-3 receptor antagonists
MX9702865A (es) Agentes estrogenicos.
BG105564A (en) Galantamine-containing composition with controlled release
HK95697A (en) 5-HT1-like receptor agonist for rectal administration
AU1767997A (en) Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhibitors
MX9505065A (es) Composicion farmaceutica, aplicable oralmente.
MX9505064A (es) Composicion farmaceutica, aplicable oralmente.
IE901862L (en) Inclusion compound of imipramine
CA2270177A1 (en) Transdermal administration of ment
EP0169392A3 (en) Triazolobenzodiazepines and pharmaceutical compositions containing them
WO2000000198A8 (en) Piperidine derivatives having effects on serotonin related systems
CA2335551A1 (en) Thyroid hormone analogues and methods for their preparation
GR3022615T3 (en) Pharmaceutical compositions based on ebastime or analogues thereof.
NO944781L (no) 2,5-diokso-2,5-dihydro-1H-benz(b)azepiner som NMDA-reseptor-antagonister
WO2000054780A3 (en) Corticosteroid formulation
GR3036195T3 (en) Novel compounds
AU648890B2 (en) Carbostyril derivatives and pharmaceutical compositions containing the same for use as a disturbance-of-consciousness improving agent, central nervous system stimulant or sigma receptor agonist
TW371661B (en) Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides
CA2129676A1 (en) Dextromethorphan Antitussive Compositions
IE890275L (en) Pharmaceutical composition for 4-aroylimidazol-2-ones
CA2270026A1 (en) Substituted bicyclic derivatives for treating central nervous system disorders

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090505